GR3035004T3 - Method and composition for the treatment of herpes related disorders. - Google Patents
Method and composition for the treatment of herpes related disorders.Info
- Publication number
- GR3035004T3 GR3035004T3 GR20000402695T GR20000402695T GR3035004T3 GR 3035004 T3 GR3035004 T3 GR 3035004T3 GR 20000402695 T GR20000402695 T GR 20000402695T GR 20000402695 T GR20000402695 T GR 20000402695T GR 3035004 T3 GR3035004 T3 GR 3035004T3
- Authority
- GR
- Greece
- Prior art keywords
- treatment
- composition
- related disorders
- herpes related
- herpes
- Prior art date
Links
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 title 1
- 208000029433 Herpesviridae infectious disease Diseases 0.000 abstract 1
- 102000005348 Neuraminidase Human genes 0.000 abstract 1
- 108010006232 Neuraminidase Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- AIDS & HIV (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68207191A | 1991-04-09 | 1991-04-09 | |
US86054692A | 1992-04-03 | 1992-04-03 | |
PCT/US1992/002745 WO1992018158A1 (en) | 1991-04-09 | 1992-04-06 | Method and composition for the treatment of herpes related disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3035004T3 true GR3035004T3 (en) | 2001-03-30 |
Family
ID=27102809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20000402695T GR3035004T3 (en) | 1991-04-09 | 2000-12-06 | Method and composition for the treatment of herpes related disorders. |
Country Status (15)
Country | Link |
---|---|
US (2) | US5558863A (el) |
EP (1) | EP0579765B1 (el) |
JP (1) | JP3266254B2 (el) |
AT (1) | ATE196424T1 (el) |
AU (1) | AU662152B2 (el) |
BR (1) | BR9205877A (el) |
CA (1) | CA2108135C (el) |
DE (1) | DE69231465T2 (el) |
DK (1) | DK0579765T3 (el) |
ES (1) | ES2151489T3 (el) |
GR (1) | GR3035004T3 (el) |
IE (1) | IE921141A1 (el) |
IL (1) | IL101540A (el) |
NO (1) | NO313489B1 (el) |
WO (1) | WO1992018158A1 (el) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL152130A0 (en) * | 2000-04-07 | 2003-05-29 | Ellis L Kline | Methods and compositions for treating neoplasms |
JP5414366B2 (ja) * | 2009-05-29 | 2014-02-12 | 独立行政法人科学技術振興機構 | 疼痛治療剤 |
KR20150063079A (ko) * | 2012-09-28 | 2015-06-08 | 엘리스 클라인 | 감염성 질환의 치료를 위한 글리코시다아제 요법 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2905678A1 (de) * | 1978-02-16 | 1979-12-20 | Science Union & Cie | Pharmazeutische zubereitungen auf der grundlage von bakterienenzymen |
JPS575916A (en) * | 1980-06-13 | 1982-01-12 | Teijin Ltd | Polyester fiber with soft touch and production of knitted and woven fabrics therefrom |
-
1992
- 1992-04-06 JP JP51137692A patent/JP3266254B2/ja not_active Expired - Fee Related
- 1992-04-06 CA CA002108135A patent/CA2108135C/en not_active Expired - Fee Related
- 1992-04-06 EP EP92911249A patent/EP0579765B1/en not_active Expired - Lifetime
- 1992-04-06 ES ES92911249T patent/ES2151489T3/es not_active Expired - Lifetime
- 1992-04-06 DE DE69231465T patent/DE69231465T2/de not_active Expired - Lifetime
- 1992-04-06 WO PCT/US1992/002745 patent/WO1992018158A1/en active IP Right Grant
- 1992-04-06 AU AU19264/92A patent/AU662152B2/en not_active Ceased
- 1992-04-06 DK DK92911249T patent/DK0579765T3/da active
- 1992-04-06 AT AT92911249T patent/ATE196424T1/de active
- 1992-04-06 BR BR9205877A patent/BR9205877A/pt not_active Application Discontinuation
- 1992-04-09 IE IE114192A patent/IE921141A1/en not_active IP Right Cessation
- 1992-04-09 IL IL10154092A patent/IL101540A/en not_active IP Right Cessation
-
1993
- 1993-10-08 NO NO19933628A patent/NO313489B1/no not_active IP Right Cessation
-
1995
- 1995-02-21 US US08/393,120 patent/US5558863A/en not_active Expired - Lifetime
-
1996
- 1996-09-19 US US08/716,053 patent/US5736133A/en not_active Expired - Lifetime
-
2000
- 2000-12-06 GR GR20000402695T patent/GR3035004T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH06506698A (ja) | 1994-07-28 |
NO933628D0 (no) | 1993-10-08 |
CA2108135C (en) | 2008-03-11 |
EP0579765A1 (en) | 1994-01-26 |
DE69231465D1 (de) | 2000-10-26 |
IL101540A (en) | 1996-10-31 |
NO933628L (no) | 1993-12-08 |
IE921141A1 (en) | 1992-10-21 |
EP0579765B1 (en) | 2000-09-20 |
NO313489B1 (no) | 2002-10-14 |
ES2151489T3 (es) | 2001-01-01 |
IL101540A0 (en) | 1992-12-30 |
CA2108135A1 (en) | 1992-10-10 |
ATE196424T1 (de) | 2000-10-15 |
AU662152B2 (en) | 1995-08-24 |
US5558863A (en) | 1996-09-24 |
JP3266254B2 (ja) | 2002-03-18 |
DE69231465T2 (de) | 2001-04-19 |
WO1992018158A1 (en) | 1992-10-29 |
BR9205877A (pt) | 1994-09-27 |
US5736133A (en) | 1998-04-07 |
DK0579765T3 (da) | 2000-10-09 |
EP0579765A4 (en) | 1994-08-24 |
AU1926492A (en) | 1992-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG101118A (en) | Therapeutical compounds | |
UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
AU3153097A (en) | Pharmaceutical for treatment of neurological and neuropsychiatric disorders | |
AU4048295A (en) | Peptide medicaments for the treatment of disease | |
MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
HU9203871D0 (en) | Pharmaceutical application of certain cistine derivatives | |
ES2182914T3 (es) | Inmunopotenciacion inducida de quitosan. | |
AU1463992A (en) | Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus | |
MX9704034A (es) | Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso. | |
AU7777794A (en) | Melatonin derivatives for use in treating sleep disorders | |
RU94041028A (ru) | Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция | |
EP0744176A3 (en) | Methods for inhibiting bone loss | |
IL105475A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS | |
DK0719276T3 (da) | Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf | |
GR3035004T3 (en) | Method and composition for the treatment of herpes related disorders. | |
IL105498A0 (en) | Pharmaceutical composition containing ribonucleotide polymerase | |
FI965114A0 (fi) | Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä | |
TW330933B (en) | Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes | |
EP0663209A3 (en) | Medicines to inhibit the effects of amyloidogenic proteins. | |
IL102815A0 (en) | Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus | |
IL100243A0 (en) | Pharmaceutical compositions for the treatment of erythrocytic malaria infections | |
ES2184121T3 (es) | Formulacion para el tratamiento y/o profilaxis de la demencia. | |
CA1263380C (en) | MYCAMINOSYLTYLONOLIDE COMPOUNDS SUBSTITUTED FOR C-23 AND PHARMACEUTICAL COMPOUNDS CONTAINING THEM | |
IL106939A0 (en) | Pharmaceutical compositions for treating viral infections | |
WO2001013910A3 (en) | Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry |